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Abstract
A regio- and stereoselective method has been developed for the synthesis of novel fluorinated 2-aminocyclohexanecarboxylic acid
derivatives with the fluorine attached to position 4 of the ring. The synthesis starts from either cis- or trans-β-aminocyclohex-4-
enecarboxylic acids and involves regio- and stereoselective transformation of the ring C–C double bond through iodooxazine for-
mation and hydroxylation, followed by hydroxy–fluorine or oxo–fluorine exchange.
Introduction
Fluorine chemistry is an expanding area of research that has
generated increasing interest in pharmaceutical and medicinal
chemistry in recent years because of its considerable impact in
drug discovery. There is currently extensive research activity in
synthetic chemistry for the preparation of various biologically
active fluorinated products [1-10].
Of special interest among such materials are the fluorinated
amino acids, which in most cases exhibit higher bioactivities
than the nonfluorinated counterparts. The fluorinated α- or
acyclic β-amino acids have acquired significance as antibacte-
rial or antifungal agents, enzyme inhibitors or as antitumoral
compounds. Introduction of a fluorinated amino acid into a
peptide may generate specific protein–ligand or protein–protein
interactions, thereby determining thermal or metabolic stabili-
ties, which is of great importance in peptide-based drug
research [11-35]. These changes in properties may be more
appreciable in the case of peptide oligomers formed from
conformationally restricted fluorinated amino acids. Although
cyclic β-amino acids are of major interest in pharmaceutical
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Scheme 1: Synthesis of all-cis ethyl 4-hydroxylated β-aminocyclohexanecarboxylate 5.
chemistry and in peptide research [36-60], only a relatively
small number of fluorinated derivatives of this class of com-
pounds have been synthesized so far [61-70].
Results and Discussion
We recently developed a synthetic method for the regio- and
stereoselective introduction of a fluorine atom onto the skeleton
of a β-aminocyclohexanecarboxylic acid. The synthesis starts
from the Boc-protected 2-aminocyclohex-4-enecarboxylic acid
or 2-aminocyclohex-3-enecarboxylic acid and involves ring
C–C bond transformation by regio- and stereoselective hydrox-
ylation via iodolactonization, followed by hydroxy–fluorine
exchange. This protocol was applied to synthesize fluorinated
β-aminocyclohexane scaffolds with the fluorine atom on
either position 3 or 5 of the ring. Whereas the procedure is a
convenient economical route to fluorinated cyclohexane or
cyclohexene β-amino acids, it did not allow extension to the
synthesis of similar derivatives with the fluorine atom on
position 4.
During our work performed to fill this gap, we have developed
a synthetic procedure for gaining access to fluorinated
β-aminocyclohexanecarboxylic acids.
This synthesis starts from ethyl cis-2-aminocyclohex-4-enecar-
boxylate 1 [57] and follows two different strategies. One is
based on regio- and stereoselective hydroxylation via iodo-
oxazine formation, followed by fluorination, while the other
includes stereoselective epoxidation and regioselective oxirane
opening, followed by hydroxy–fluorine exchange. In the former
protocol, amino ester 1 is treated with KI/I2 in H2O/CH2Cl2,
which affords iodooxazinone derivative 2 stereo- and regiose-
lectively (Scheme 1, Figure 1). Next, compound 2 is trans-
formed to 3 by amide N-Boc protection with Boc2O and
4-dimethylaminopyridine (DMAP) in THF. Removal of the
iodine from the cyclohexane skeleton in 3 is accomplished
under reductive conditions. On treatment with n-Bu3SnH in the
presence of a catalytic amount of azobisisobutyronitrile (AIBN)
in dichloromethane under reflux, 3 undergoes deiodination to
give ester 4 in 70% yield. Oxazinone 4 is then subjected to
heterocycle ring opening with NaOEt in EtOH at 0 °C to furnish
all-cis hydroxylated amino ester 5 with the hydroxy group on
position 4 of the skeleton (Scheme 1, Figure 2).
Figure 1: ORTEP diagram of iodooxazinone 2. Thermal ellipsoids
have been drawn at the 20 % probability level.
Hydroxylated amino ester 5 was also prepared via the alter-
native route involving stereoselective epoxidation. Cyclo-
hexene β-amino ester 1 underwent C–C double bond oxidation
with 3-chloroperbenzoic acid (MCPBA) to afford epoxy amino
ester 6 cis-diastereoselectively [57] (Scheme 1). Opening of the
oxirane ring in 6 with NaBH4 in EtOH at 70 °C proceeded
regioselectively, providing exclusively amino ester 5 with the
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Scheme 3: Synthesis of ethyl 4-hydroxy-β-aminocyclohexanecarboxylate 14.
Figure 2: ORTEP diagram of hydroxylated amino ester 5. Thermal
ellipsoids have been drawn at the 20% probability level.
hydroxy function on position 4 (for analogous transformations,
see reference [60]).
Hydroxylated amino ester 5 was next further used as a key com-
pound for the synthesis of fluorinated target materials. A fluo-
rine atom was introduced by hydroxy–fluorine exchange with
bis(dimethoxyethylaminosulfur trifluoride) (Deoxo-Fluor®)
reagent. The reaction was carried out under different experi-
mental conditions, with variation of the temperature (−40 °C,
0 °C or 20 °C) and the solvent (toluene, CH2Cl2 or THF).
Finally, it was found that hydroxylated amino ester 5 under-
went inversion on reaction with a 50% Deoxo-Fluor toluene
solution in CH2Cl2 at 0 °C [68,69] to give monofluorinated
cyclohexane amino ester 7 in 32% yield (Scheme 2). This rather
modest yield is attributed to the relatively large amount of elim-
ination materials (40% overall). In continuation, the geminal
difluorinated β-aminocyclohexanecarboxylic acid derivative
with the fluorine atoms on position 4 was efficiently synthe-
sized. Oxidation of the hydroxy group of amino ester 5 with
pyridinium chlorochromate (PCC) in CH2Cl2 yielded the
corresponding oxo-group-containing amino ester 8, which was
then converted with Deoxo-Fluor in CH2Cl2 at 0 °C to the
corresponding geminal difluoro amino ester 9 in good yield
(Scheme 2).
Scheme 2: Syntheses of fluorinated amino esters 7 and 9.
The synthetic route presented above could be extended to the
preparation of other 4-fluorinated cyclohexane amino acid
derivatives, stereoisomers of 7 or 9. Ethyl trans-2-aminocyclo-
hex-4-enecarboxylate 10 [57] was analogously transformed to
its cis counterpart through regio- and stereoselective iodo-
oxazine formation with KI/I2 to give compound 11 (Scheme 3).
N-Protection of 11, followed by reductive deiodination,
proceeded via 12 (Figure 3) to afford ester 13. Opening of the
heterocyclic ring with NaOEt in EtOH at 0 °C furnished
4-hydroxylated amino ester 14, a stereoisomer of 5 (Scheme 3,
Figure 4).
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Figure 3: ORTEP diagram of iodooxazinone derivative 12. Thermal
ellipsoids have been drawn at the 20% probability level.
Figure 4: ORTEP diagram of hydroxylated amino ester 14. The water
molecule oxygen atom O4 is situated on the twofold axis with a popu-
lation parameter of 0.6. Thermal ellipsoids have been drawn at the
20% probability level.
It is noteworthy that in this latter case hydroxylated amino ester
14 could not be prepared by the alternative diastereoselective
epoxidation and regioselective oxirane opening strategy:
according to our previous results, the opening of epoxide 15
derived from 10 proceeded via a trans-diaxial chair con-
formation with the nucleophile attack on C4, thereby providing
the 5-hydroxylated derivative [57,60].
Next, hydroxylated cyclohexane amino ester 14 was converted
with Deoxo-Fluor in CH2Cl2 at 0 °C to 4-fluorinated ethyl
β-aminocyclohexanecarboxylate 16, a stereoisomer of 7. Unfor-
tunately, the formation of a substantial amount of a mixture of
elimination material could again not be avoided. When
subjected to oxidation with PCC, amino ester 14 gave the
corresponding oxo ester 17, treatment of which with Deoxo-
Fluor in CH2Cl2 at 0 °C provided geminal 4,4-difluorinated
cyclohexane amino ester 18, a stereoisomer of 9 (Scheme 4).
Scheme 4: Syntheses of fluorinated amino esters 16 and 18.
Conclusion
In conclusion, a simple and convenient procedure has been
developed for the introduction of one or two fluorine atoms
onto the skeleton of either cis- or trans-β-aminocyclohexanecar-
boxylates. The synthetic concept involves regio- and stereose-
lective hydroxylation via iodooxazine formation, followed by
hydroxy–fluorine or oxo–fluorine exchange.
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